7.6.2.1	1-monoolein	0.5 mM significantly reduce the P-glycoprotein protein expression, 0.1 mM of 1-monoolein does not have any significant effect on the expression of P-glycoprotein	19869	
7.6.2.1	1-monostearin	0.5 mM significantly reduce the P-glycoprotein protein expression, 0.1 mM of 1-monostearin does not have any significant effect on the expression of P-glycoprotein	31725	
7.6.2.1	4-(2-aminoethyl)benzenesulfonyl fluoride	flippase activity for 1-oleoyl-2-[6-(7-nitrol-2-1,3-benzonadiol-4-yl)amino]-sn-glycerophosphoethanolamine is inhibited by 72% at 5 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, flippase activity for 1-oleoyl-2-[6-(7-nitrol-2-1,3-benzonadiol-4-yl)amino]-sn-glycerophosphocholine is inhibited by 75% at 5 mM 4-(2-aminoethyl)benzenesulfonyl fluoride	4308	
7.6.2.1	4-hydroxy-2-nonenal	-	1426	
7.6.2.1	5,5'-dithiobis(2-nitrobenzoic acid)	flippase activity for 1-oleoyl-2-[6-(7-nitrol-2-1,3-benzonadiol-4-yl)amino]-sn-glycerophosphoethanolamine is inhibited by 80% at 20 mM 5,5'-dithiobis(2-nitrobenzoic acid), flippase activity for 1-oleoyl-2-[6-(7-nitrol-2-1,3-benzonadiol-4-yl)amino]-sn-glycerophosphocholine is inhibited by 60% at 20 mM 5,5'-dithiobis(2-nitrobenzoic acid)	221	
7.6.2.1	acrolein	-	1198	
7.6.2.1	AlFx	trapping of MsbA with 0.8 mM AlFx results in incomplete inhibition of activity	169879	
7.6.2.1	AMP-PNP	-	4099	
7.6.2.1	azide	-	230	
7.6.2.1	Bcl-2	PLS3 and tBid may form a bidirectional positive feedback loop that is antagonized by Bcl-2	17958